In the treatment of shock, why is dobutamine preferred over dopamine?
Which of the following is NOT typically administered during an anaphylactic reaction?
What is the best and most effective drug to control convulsions in toxicity cases?
A 70-year-old man was administered penicillin intravenously. Within 5 minutes, he developed generalized urticaria, swelling of lips, hypotension, and bronchospasm. What is the first choice of treatment?
What is the principal action of ammonia in syncope?
A patient develops facial puffiness, rash, hypotension, and breathing difficulty after the administration of antibiotics. What is the immediate treatment?
In anaphylactic shock, by which route is epinephrine administered?
Which of the following drugs is used in CPR?
Glucagon hydrochloride is used in poisoning of which class of drugs?
Which drug is primarily used in the management of anaphylaxis?
Explanation: **Explanation:** Dobutamine is often preferred over Dopamine in specific shock scenarios (particularly cardiogenic shock) due to its more favorable pharmacological profile and lower side-effect burden. **1. Why the Correct Answer (D) is Right:** * **Fewer Arrhythmias (Option A):** While both are inotropes, Dopamine significantly increases endogenous norepinephrine release. This, combined with its strong $\beta_1$ and $\alpha$ effects at higher doses, makes it more **arrhythmogenic** than Dobutamine. * **Less Renal Vasodilation (Option B):** This is a comparative pharmacological fact. While low-dose Dopamine acts on $D_1$ receptors to cause renal vasodilation, Dobutamine lacks this specific dopaminergic activity. In the context of the question, the absence of this "distracting" vasodilator effect allows for more predictable hemodynamic management in heart failure. * **Less Coronary Vasoconstriction (Option C):** At higher doses, Dopamine stimulates $\alpha_1$ receptors, leading to systemic and **coronary vasoconstriction**, which increases myocardial oxygen demand and can worsen ischemia. Dobutamine has mild $\beta_2$ activity which promotes vasodilation, reducing afterload and improving coronary perfusion. **2. Clinical Pearls for NEET-PG:** * **Mechanism:** Dobutamine is a relatively selective **$\beta_1$ agonist** (Inotrope > Chronotrope). * **Drug of Choice:** Dobutamine is the preferred inotrope for **Cardiogenic Shock** and is used in **Stress Echocardiography**. * **The "Dopamine Myth":** Modern trials (like the SOAP II trial) have shown that Dopamine is associated with higher mortality and more arrhythmic events compared to Norepinephrine/Dobutamine, leading to its declining use in clinical practice. * **Side Effect:** The most common side effect of Dobutamine is tachycardia.
Explanation: Anaphylaxis is a severe, life-threatening Type I hypersensitivity reaction characterized by systemic vasodilation, increased capillary permeability, and bronchospasm [1]. The management focuses on reversing these physiological derangements. **Why Blood Transfusion is the correct answer:** Blood transfusion is **not** a treatment for anaphylaxis. In fact, blood products are a common *cause* of anaphylactic reactions (IgA deficiency-mediated). Anaphylaxis results in **distributive shock** (fluid shifting from vessels to tissues), not hemorrhagic shock. The appropriate fluid resuscitation involves rapid infusion of **Isotonic Crystalloids** (Normal Saline) to restore intravascular volume, not blood. **Why the other options are incorrect:** * **Epinephrine (Adrenaline):** The **drug of choice**. Its $\alpha_1$ agonist effect causes vasoconstriction (reducing edema and hypotension), while $\beta_2$ effects cause bronchodilation and inhibit further mast cell degranulation [1]. * **Antihistamines (H1 & H2 blockers):** Used as **adjuvant therapy** to manage cutaneous symptoms like urticaria and itching. They do not treat airway obstruction or hypotension. * **Beta-adrenergic agonists (e.g., Salbutamol):** Administered via nebulization to treat refractory bronchospasm that does not fully respond to epinephrine. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Epinephrine:** Always **Intramuscular (IM)** in the anterolateral thigh (1:1000 concentration). Dose: 0.5 mg in adults; 0.01 mg/kg in children. * **Biphasic Reaction:** Symptoms can recur 1–72 hours after initial resolution; hence, patients must be observed. * **Refractory Cases:** If a patient is on **Beta-blockers** and unresponsive to epinephrine, the antidote/alternative is **Glucagon**.
Explanation: **Explanation:** The correct answer is **Diazepam (Option C)**. **Why Diazepam is the Drug of Choice:** In the context of acute toxicity (poisoning) or drug-induced seizures, the primary goal is rapid termination of seizure activity to prevent hyperthermia, rhabdomyolysis, and metabolic acidosis. **Benzodiazepines (BZDs)** like Diazepam are the first-line agents because they act rapidly by enhancing GABA-mediated inhibition via the $GABA_A$ receptor. Diazepam is highly lipid-soluble, allowing it to cross the blood-brain barrier almost immediately after intravenous administration, making it the most effective "rescue" drug in emergency toxicology. **Analysis of Incorrect Options:** * **Phenytoin (Option B):** It is generally **ineffective** for toxin-induced seizures (e.g., theophylline, isoniazid, or cocaine toxicity). It has a slow onset of action and does not act on the GABAergic pathways typically disrupted by toxins. * **Phenobarbitone (Option A):** While effective as a second-line agent, it causes significant respiratory depression and sedation. It is usually reserved for seizures refractory to benzodiazepines. * **Carbamazepine (Option D):** This is a maintenance antiepileptic drug for focal seizures. It has no role in emergency seizure control and can actually worsen seizures in certain toxicities (e.g., tricyclic antidepressant overdose). **High-Yield Clinical Pearls for NEET-PG:** * **First-line for Status Epilepticus:** Lorazepam (due to longer duration of action in the brain) or Diazepam. * **Specific Antidote Exception:** For **Isoniazid (INH)** induced convulsions, the specific treatment is **Intravenous Pyridoxine (Vitamin B6)**, though Diazepam is used adjunctively. * **Avoid Phenytoin** in seizures caused by local anesthetic toxicity or TCA overdose as it may exacerbate cardiac arrhythmias.
Explanation: ### Explanation **Correct Answer: B. Epinephrine injection** The patient is presenting with **Anaphylaxis**, a life-threatening Type I hypersensitivity reaction characterized by multi-system involvement (skin, respiratory, and cardiovascular). **Epinephrine (Adrenaline)** is the drug of choice and must be administered immediately. **Why Epinephrine is the First Choice:** Epinephrine acts as a **physiological antagonist** to histamine and other mediators. Its mechanism of action addresses all life-threatening components of anaphylaxis: * **$\alpha_1$ agonism:** Causes vasoconstriction, which increases peripheral vascular resistance to treat hypotension and reduces mucosal edema (laryngeal edema). * **$\beta_1$ agonism:** Increases cardiac contractility and heart rate (positive inotropic and chronotropic effects). * **$\beta_2$ agonism:** Causes potent bronchodilation and inhibits further mediator release from mast cells and basophils. **Why Other Options are Incorrect:** * **A. Chlorpheniramine:** This is an H1-antihistamine. While it helps with urticaria and itching, it is too slow-acting and does not treat life-threatening airway obstruction or shock. * **C. Hydrocortisone:** Corticosteroids have a delayed onset of action (4–6 hours). They are used to prevent "biphasic reactions" (delayed recurrence of symptoms) but are never the primary treatment for acute anaphylaxis. * **D. Nebulized Salbutamol:** This treats bronchospasm but does not address laryngeal edema or circulatory collapse. It is only an adjunct therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Choice:** Intramuscular (IM) in the anterolateral thigh (vastus lateralis) is preferred over SC or IV in the initial setting due to rapid absorption and safety. * **Dose/Concentration:** 0.5 mg (0.5 ml of **1:1000** solution) IM for adults. * **Mechanism:** Physiological antagonism (different receptor, opposite action). * **Drug of Choice for Anaphylactic Shock:** Epinephrine. * **Drug of Choice for Acute Bronchial Asthma:** Salbutamol (Selective $\beta_2$ agonist).
Explanation: **Explanation:** The correct answer is **B. Respiratory stimulant.** **Mechanism of Action:** Ammonia (often administered as "smelling salts" or aromatic spirits of ammonia) acts as a **reflex respiratory stimulant**. When inhaled, the pungent ammonia gas causes acute irritation of the sensory nerve endings (primarily the trigeminal nerve) in the nasal mucosa and upper respiratory tract. This irritation triggers a rapid, reflex stimulation of the **medullary respiratory center**, leading to an increased rate and depth of breathing. This surge in ventilation helps increase oxygenation and can facilitate the restoration of consciousness in patients experiencing vasovagal syncope. **Analysis of Incorrect Options:** * **A & D (Vasomotor stimulant/Inhibitor):** While the sympathetic surge following the irritation may cause a transient rise in blood pressure, ammonia does not have a direct or primary pharmacological action on the vasomotor center or vascular smooth muscle. * **C (Vagal stimulant):** Vagal stimulation would cause bradycardia and a further drop in blood pressure, which would worsen syncope. Ammonia aims to counteract the overactive vagal tone seen in common fainting. **NEET-PG High-Yield Pearls:** * **Clinical Use:** Ammonia is used for "simple fainting" (vasovagal syncope) but is contraindicated if a head, neck, or back injury is suspected, as the reflex "jerking" of the head away from the inhalant could worsen spinal injuries. * **Classification:** It is categorized as a **reflex stimulant** (acting via peripheral irritation) rather than a direct stimulant (like Caffeine or Theophylline which act directly on the CNS). * **Differential:** Do not confuse this with the treatment of hepatic encephalopathy, where the goal is to *lower* systemic ammonia levels.
Explanation: ### Explanation **Diagnosis:** The patient is presenting with **Anaphylaxis**, a Type I hypersensitivity reaction characterized by angioedema (facial puffiness), urticaria (rash), bronchospasm (breathing difficulty), and distributive shock (hypotension). **Why Option A is Correct:** Adrenaline (Epinephrine) is the drug of choice for anaphylaxis. It acts as a physiological antagonist to histamine. Its **α1-agonist** effects increase peripheral vascular resistance to treat hypotension, while its **β2-agonist** effects cause bronchodilation and inhibit further mast cell degranulation. * **Route:** The **Intramuscular (IM)** route in the anterolateral thigh is preferred because it achieves peak plasma concentrations faster and has a superior safety profile compared to the IV route. * **Dose/Dilution:** The standard adult dose is **0.5 mg (0.5 ml)** of a **1:1000** concentration. **Why Other Options are Incorrect:** * **Options B & C:** IV adrenaline (1:10,000) is reserved for patients with profound hypotension or cardiac arrest who have failed to respond to multiple IM injections. Giving IV adrenaline as a first-line treatment in a conscious patient carries a high risk of fatal arrhythmias and severe hypertension. * **Option D:** Giving a **1:1000** dilution via the **IV route** is a critical medical error. This concentration is ten times more potent than the standard IV preparation and can cause immediate myocardial infarction or intracranial hemorrhage. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Injection:** Vastus lateralis (lateral thigh) is preferred over the deltoid due to better absorption. * **Pediatric Dose:** 0.01 mg/kg (up to 0.3 mg) of 1:1000 IM. * **Second-line drugs:** Hydrocortisone and Pheniramine are used to prevent "biphasic reactions" but are **never** the first-line treatment. * **Glucagon:** The drug of choice for anaphylaxis in patients taking **Beta-blockers** who are refractory to adrenaline.
Explanation: **Explanation:** In the management of anaphylactic shock, **Intramuscular (IM) epinephrine** is the first-line treatment of choice. The preferred site is the **anterolateral aspect of the middle third of the thigh** (vastus lateralis muscle). **Why Intramuscular is Correct:** * **Rapid Absorption:** The thigh muscle is highly vascular, ensuring faster peak plasma concentrations compared to the subcutaneous route. * **Safety Profile:** It has a superior safety profile compared to the intravenous (IV) route, with a lower risk of inducing lethal arrhythmias or severe hypertension. * **Efficacy:** It effectively reverses airway edema, hypotension, and bronchoconstriction by acting on $\alpha_1$, $\beta_1$, and $\beta_2$ receptors. **Why Other Options are Incorrect:** * **Intravenous (IV):** Reserved only for profound shock or patients not responding to multiple IM doses. It requires cardiac monitoring due to the high risk of tachyarrhythmias and myocardial infarction. * **Subcutaneous (SC):** Absorption is slow and unpredictable, especially in shock states where peripheral vasoconstriction further delays drug entry into the systemic circulation. * **Oral:** Epinephrine is rapidly metabolized by enzymes in the GI tract (MAO and COMT) and undergoes extensive first-pass metabolism, making it ineffective via this route. **High-Yield Clinical Pearls for NEET-PG:** * **Concentration:** Use **1:1000** (1 mg/ml) for IM and **1:10,000** (0.1 mg/ml) for IV. * **Standard Dose:** 0.3 to 0.5 mg in adults; 0.01 mg/kg in children. * **Mechanism:** It is a physiological antagonist to histamine. * **DOC:** Epinephrine is the Drug of Choice for Anaphylactic shock, whereas Noradrenaline is the DOC for Septic shock.
Explanation: **Explanation** In the management of Cardiac Arrest, the current **AHA/ACLS Guidelines** emphasize the use of specific anti-arrhythmics for shock-refractory Ventricular Fibrillation (VF) or pulseless Ventricular Tachycardia (pVT). **Why Amiodarone is Correct:** Amiodarone is a Class III anti-arrhythmic that blocks potassium channels (prolonging repolarization) while also possessing sodium, calcium, and alpha/beta-adrenergic blocking properties. It is the **first-line anti-arrhythmic** drug used in CPR for VF/pVT that is unresponsive to defibrillation and vasopressors (Epinephrine). It improves the rates of ROSC (Return of Spontaneous Circulation) and survival to hospital admission. **Analysis of Incorrect Options:** * **Atropine (A):** Previously used for Asystole/PEA, it was **removed** from the ACLS Cardiac Arrest Algorithm in 2010. It is now primarily used for symptomatic bradycardia. * **Procainamide (C):** While a potent anti-arrhythmic (Class Ia), it is used for stable wide-complex tachycardia. It is not recommended during active CPR/cardiac arrest due to its potential to cause hypotension and its long infusion time. * **Phenylephrine (D):** This is a pure alpha-1 agonist used for hypotension/shock. Epinephrine is the preferred vasopressor in CPR because its beta-1 activity increases coronary and cerebral perfusion pressure. **High-Yield NEET-PG Pearls:** * **Amiodarone Dose in CPR:** Initial bolus of **300mg** IV/IO, followed by a second dose of **150mg** if needed. * **Alternative:** **Lidocaine** (1–1.5 mg/kg) is the alternative to Amiodarone if the latter is unavailable. * **Drug of Choice for Torsades de Pointes:** Magnesium Sulfate. * **Standard Vasopressor:** Epinephrine 1mg every 3–5 minutes remains the backbone of CPR pharmacology.
Explanation: **Explanation** **Glucagon** is the specific antidote of choice for **Beta-blocker (BB) overdose** [1]. 1. **Mechanism of Action (Why A is correct):** Beta-blockers cause bradycardia and hypotension by blocking $\beta_1$ receptors, leading to decreased intracellular **cyclic AMP (cAMP)**. Glucagon acts as a "physiological bypass." It binds to specific G-protein coupled receptors on the myocardium that are independent of beta-receptors. This activation stimulates **adenylyl cyclase**, which increases intracellular cAMP levels [1]. The result is a potent **positive inotropic** (increased contractility) and **chronotropic** (increased heart rate) effect, effectively reversing the cardiotoxicity of the beta-blocker. 2. **Analysis of Incorrect Options:** * **B. Calcium Channel Blockers (CCB):** While Glucagon is sometimes used as a second-line agent in CCB toxicity, the primary treatment is **Intravenous Calcium** and **High-dose Insulin Euglycemic Therapy (HIET)**. * **C. Tricyclic Antidepressants (TCA):** The mainstay of treatment for TCA-induced cardiotoxicity (QRS widening) is **Sodium Bicarbonate** [2]. * **D. SSRI:** SSRI overdose is rarely fatal and is managed supportively [3]. If Serotonin Syndrome occurs, the specific antidote is **Cyproheptadine**. **High-Yield Clinical Pearls for NEET-PG:** * **Glucagon Side Effect:** High-dose glucagon often causes significant **vomiting** [1]; ensure airway protection (aspiration risk). * **Other uses of Glucagon:** Acute management of severe hypoglycemia and relaxing the lower esophageal sphincter for food bolus impaction [1]. * **BB Overdose Triad:** Bradycardia, Hypotension, and Hypoglycemia (especially in children).
Explanation: **Explanation:** **Epinephrine (Adrenaline)** is the drug of choice and the first-line treatment for anaphylaxis. The underlying medical concept is its ability to act as a **physiological antagonist** to histamine and other inflammatory mediators released during a type I hypersensitivity reaction. * **$\alpha_1$ agonism:** Causes vasoconstriction, which increases peripheral vascular resistance to treat hypotension and reduces mucosal edema (laryngeal edema). * **$\beta_1$ agonism:** Increases cardiac output (positive inotropic and chronotropic effects). * **$\beta_2$ agonism:** Leads to bronchodilation and, crucially, inhibits further mast cell degranulation. **Why other options are incorrect:** * **Norepinephrine:** Primarily an $\alpha_1$ and $\beta_1$ agonist with negligible $\beta_2$ activity. While it treats hypotension, it lacks the essential bronchodilatory effect needed in anaphylaxis. * **Dopamine:** Used mainly in cardiogenic or septic shock; it does not address the multi-system allergic components (bronchospasm/edema) of anaphylaxis. * **Antihistaminics:** These are **second-line** agents. They are too slow-acting for emergencies and do not treat life-threatening airway obstruction or cardiovascular collapse. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** The preferred route in an emergency is **Intramuscular (IM)** in the anterolateral thigh (vastus lateralis) due to rapid absorption. * **Concentration:** Use **1:1000** (1 mg/ml) for IM and **1:10,000** (0.1 mg/ml) for IV (only if IM fails or in cardiac arrest). * **Standard Dose:** 0.3 to 0.5 mg in adults; 0.01 mg/kg in children. * **Glucagon:** If a patient on **Beta-blockers** develops anaphylaxis and does not respond to Epinephrine, Glucagon is the drug of choice.
Management of Anaphylaxis
Practice Questions
Drugs in Cardiac Arrest
Practice Questions
Status Epilepticus Management
Practice Questions
Acute Stroke Therapeutics
Practice Questions
Toxicological Emergencies
Practice Questions
Antidotes in Emergency Medicine
Practice Questions
Pain Management in Emergency
Practice Questions
Sedation and Paralysis in Emergency
Practice Questions
Drugs in Traumatic Emergencies
Practice Questions
Thrombolysis in Emergency Settings
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free